Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.5ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
EG.1.5ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
EG.1.5ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-17292.3China
EG.1.5SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-18611Singapore
EG.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.1.5NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
EG.1.5SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
XBB.8ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
XBB.8ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
XBB.8ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-17292.3China
XBB.8SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
XBB.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.8NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
XBB.8SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
XAY.2.3ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
XAY.2.3ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
XAY.2.3ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
XAY.2.3SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
XAY.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.2.3NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
XAY.2.3SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
CH.1.1.8ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
CH.1.1.8ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
CH.1.1.8ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
CH.1.1.8SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
CH.1.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.8NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
CH.1.1.8SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.2.36ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
BA.5.2.36ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BA.5.2.36ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
BA.5.2.36SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
BA.5.2.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.36NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BA.5.2.36SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
BV.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
BV.1ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BV.1ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
BV.1SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
BV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BV.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BV.1SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BF.26ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
BF.26ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
BF.26ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
BF.26SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
BF.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.26NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BF.26SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BA.5.1.33ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used